2.8 CHF
46.01 M CHF
496.24 M CHF
6.10 M
About MEDACTA GROUP N
Sector
Industry
CEO
Francesco Siccardi
Website
Headquarters
Castel San Pietro
Founded
1999
ISIN
CH0468525222
FIGI
BBG00NPRXKM7
Medacta Group SA engages in the development, manufacture, and distribution of orthopedic and neurosurgical medical devices. The firm offers personalized kinematic models and three-dimensional planning tools for use in hip, knee, shoulder, and spine procedures. It operates through the following geographical segments: Europe, North America, Asia Pacific, and Rest of the World. The company was founded by Alberto Siccardi in 1999 and is headquartered in Castel San Pietro, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MOVE is 106.8 CHF — it has decreased by −1.66% in the past 24 hours. Watch MEDACTA GROUP N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange MEDACTA GROUP N stocks are traded under the ticker MOVE.
MOVE stock has risen by 2.11% compared to the previous week, the month change is a −6.82% fall, over the last year MEDACTA GROUP N has showed a −16.43% decrease.
We've gathered analysts' opinions on MEDACTA GROUP N future price: according to them, MOVE price has a max estimate of 150.42 CHF and a min estimate of 128.76 CHF. Watch MOVE chart and read a more detailed MEDACTA GROUP N stock forecast: see what analysts think of MEDACTA GROUP N and suggest that you do with its stocks.
MOVE reached its all-time high on Oct 18, 2021 with the price of 173.0 CHF, and its all-time low was 39.8 CHF and was reached on Mar 19, 2020. View more price dynamics on MOVE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MOVE stock is 1.69% volatile and has beta coefficient of 0.84. Track MEDACTA GROUP N stock price on the chart and check out the list of the most volatile stocks — is MEDACTA GROUP N there?
Today MEDACTA GROUP N has the market capitalization of 2.16 B, it has decreased by −1.29% over the last week.
Yes, you can track MEDACTA GROUP N financials in yearly and quarterly reports right on TradingView.
MEDACTA GROUP N revenue for the last half-year amounts to 277.92 M CHF, despite the estimated figure of 278.11 M CHF. In the next half-year revenue is expected to reach 274.96 M CHF.
MOVE net income for the last half-year is 36.53 M CHF, while the previous report showed 17.45 M CHF of net income which accounts for 109.39% change. Track more MEDACTA GROUP N financial stats to get the full picture.
MEDACTA GROUP N dividend yield was 0.44% in 2023, and payout ratio reached 23.85%. The year before the numbers were 0.52% and 23.24% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 1.73 K employees. See our rating of the largest employees — is MEDACTA GROUP N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDACTA GROUP N EBITDA is 133.71 M CHF, and current EBITDA margin is 26.32%. See more stats in MEDACTA GROUP N financial statements.
Like other stocks, MOVE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDACTA GROUP N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDACTA GROUP N technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDACTA GROUP N stock shows the strong sell signal. See more of MEDACTA GROUP N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.